Avacta chief technology officer, Dr Matt Johnson is presenting at the Annual Biomarkers & Precision Medicine Congress in San Diego which ends tomorrow.

Johnson will be presenting new Affimer applications including data from a collaboration with Covance, part of LabCorp, one of the world's largest contract research organisations.


At 8:00am: (LON:AVCT) Avacta Group PLC share price was +0.5p at 72p